TELOSTIM 250
Food supplement declared in France, declaration No 2017-8-592
TELOSTIM 250 is a food supplement declared in France. Status: retiré du marché le 9 November 2021. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- I D E C THERAPEUTIC
- Status
- Retiré du marché le 9 November 2021
- Form
- Gélule
- Daily dose
- 1 gélule par jour
- Not recommended for (according to the manufacturer)
- Antécédent de cancer du sein
Declaration 283017, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 9 November 2021, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Astragalus membranaceus Moench | Racine | Extrait sec aqueux | 100 mg |
Other active ingredients
| Name | Per day |
|---|---|
| S-Adenosyl-L-Méthionine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| L-sélénométhionine | Sélénium | 255 µg | 50 µg |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Citrate de zinc | Zinc | 25 mg | 15 mg |
Additives
Hydroxypropyl Méthyl Cellulose
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.